Name: C4 Therapeutics, Inc. (CCCC) Balance Sheet
Creator: FinSpry

C4 Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for C4 Therapeutics, Inc. (CCCC) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	55.50	253.68	29.75	309.28	181.73
Short-Term Investments	189.41	127.09	246.40	233.16	189.96
Cash & Short-Term Investments	244.90	253.68	276.15	309.28	371.69
Accounts Receivable	3.10	11.80	1.47	5.72	4.48
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	9.76	5.71	9.93	10.69	4.84
Total Current Assets	257.77	271.19	287.56	325.69	381.01
Non-Current Assets
Property, Plant & Equipment (Net)	63.38	71.09	77.52	35.05	16.55
Long-Term Investments	22.36	28.01	60.96	142.20	0.00
Other Non-Current Assets	6.10	6.17	4.81	3.82	2.58
Total Non-Current Assets	91.84	105.26	143.28	181.08	0.00
Total Assets	349.60	376.45	430.84	506.77	400.14
Current Liabilities
Accounts Payable	1.33	22.08	1.17	18.11	5.68
Short-Term Debt	5.77	0.00	2.29	0.00	0.00
Current Portion of Long-Term Debt	0.00	0.00	2.29	0.00	0.00
Accrued Liabilities	17.49	11.24	16.66	13.19	9.06
Deferred Revenue	18.71	15.47	16.62	31.80	27.60
Other Current Liabilities	1.87	2.04	3.11	0.41	0.47
Total Current Liabilities	45.18	42.77	44.55	51.25	43.85
Non-Current Liabilities
Long-Term Debt	59.98	65.76	9.20	41.55	10.05
Other Non-Current Liabilities	0.00	37.29	33.51	56.17	0.00
Total Non-Current Liabilities	88.44	87.57	97.06	65.91	0.00
Total Liabilities	133.62	130.34	141.61	117.16	119.35
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.00
Retained Earnings	-633.70	-528.51	-395.89	-268.49	-183.82
Accumulated Other Comprehensive Income	0.05	-0.13	-4.14	-0.78	0.01
Additional Paid-in Capital	849.63	774.62	689.26	658.09	0.00
Shares Outstanding	70.63	60.47	48.97	48.69	0.00
Total Stockholders' Equity	215.99	246.11	289.23	389.61	280.79
Total Liabilities & Equity	349.60	376.45	430.84	506.77	0.00